Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.04.16.718980

In silico structural analysis of EthA substitutions for ranking priority mutations leading to ethionamide resistance in Mycobacterium tuberculosis

Abstract

BackgroundTuberculosis (TB) is the second-leading cause of deaths from infectious agents and remains a global health threat. Ethionamide (ETH) is a prodrug used in regimens for multidrug-resistant TB, and, partly due to side effects that can lead to low treatment adhesion, resistance arises. Changes in EthA, the monooxygenase that activates ETH, are the main mechanism of resistance. Yet, of hundreds of EthA substitutions found in resistant isolates, only a handful have been annotated as resistance determinants. ResultsAn in silico analysis was carried out on a previously described panel of Mycobacterium tuberculosis clinical isolates for which genomes and ETH susceptibility testing results were available. EthA substitutions were mapped, revealing the existence of hotspots in its sequence. Visualization of the hotspots in the EthA structural model shows that they cluster in three regions, including ligand binding pockets. Models were built of twenty-three variants found in resistant isolates and changes in local configuration was mapped to identify investigate impact on ETH activation. Information from these models contributed to establishing five criteria for scoring whether substitutions are most likely to lead to resistance. Using these criteria, EthA D58G was selected and its expression is shown to increase growth in high ETH concentrations. ConclusionFunctionally relevant regions of EthA are revealed and point out priority substitutions for functional studies, enhancing identification and detection of substitutions not been previously associated with resistance.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Machado, R. F., Cardoso, S. L., Pinheiro, I. C., Ramos, J. P., Antunes, C., Capriles, P., Galvao, T. C.. 2026-04-17. In silico structural analysis of EthA substitutions for ranking priority mutations leading to ethionamide resistance in Mycobacterium tuberculosis. https://doi.org/10.64898/2026.04.16.718980

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Tryptophan catabolism drives AhR-dependent macropinocytosis and tumorigenesis in tuberous sclerosis complex

Tuberous sclerosis complex (TSC) is a rare genetic disorder characterized by hamartomatous tumors of the brain, skin, kidney and lung (lymphangioleiomyomatosis, LAM). TSC and LAM arise from biallelic inactivation of TSC1 or TSC2 which drives metabolic reprogramming, including macropinocytic scavenging of extracellular nutrients. To determine which nutrients sustain macropinocytosis, we measured dextran uptake after repletion of individual essential amino acids. Unexpectedly, only tryptophan (Trp) stimulated uptake in TSC2-deficient cells by 2.8-fold compared to amino acid-free medium (p < 0.0001), with no effect in TSC2-expressing cells. Steady-state metabolomics revealed that Trp supplementation raised intracellular Trp by 3.5-fold and lowered kynurenine by 60%. IDO1 inhibition abolished the response, indicating that Trp catabolism rather than Trp itself is the proximal signal. Interestingly, Ido1, Tdo2 and AhR were markedly upregulated in TSC2-deficient cells, and rapamycin repressed Ido1 and Tdo2 but not AhR. AhR was constitutively nuclear in TSC2-deficient cells, and rapamycin or the AhR antagonist CH-223191 returned it to the cytoplasm. Inhibition of IDO1, (Linrodostat), TDO2 (LM10) or AhR (StemRegenin 1, CH-223191) selectively decreased macropinocytosis and proliferation of TSC2-deficient cells. AhR antagonism also depleted glutathione by 70%. In vivo, StemRegenin 1 and CH-223191 reduced tumor volume by approximately 70% and 90% (p < 0.0001), respectively. Additionally, targeting AhR in the TSC2-deficient tumors strongly decreased mTORC1 activity. Collectively, our data identify a Trp-kynurenine-AhR axis that supports macropinocytosis in TSC2-deficient cells, and suggest AhR antagonists as a novel therapeutic approach for the treatment of TSC and LAM.

molecular biology↗

Direct Sputum Sequencing Reveals Mycobacterium tuberculosis Diversity Underrepresented by Culture in a High TB-Burden Setting

Background: Whole-genome sequencing of Mycobacterium tuberculosis (Mtb) commonly relies on culture-derived isolates, potentially altering the bacterial populations represented. Direct sputum whole-genome sequencing (dsWGS) may better capture lineage composition and within-host variant diversity. Methods: We compared targeted-enrichment dsWGS with WGS of matched culture-derived isolates from participants initiating treatment for rifampicin-susceptible pulmonary tuberculosis in Worcester, South Africa. We assessed sequencing performance, technical reproducibility, sputum-sampling variability, lineage and variant concordance, and resistance-associated variation, and explored associations with baseline clinical characteristics and treatment response. Results: Of 218 clinical dsWGS reactions, 139 passed sequencing quality criteria, yielding 113 eligible baseline sputum-culture pairs. Mixed-lineage infection was detected in 72/113 (63.7%) sputum specimens versus 7/113 (6.2%) matched cultures; 66/113 (58.4%) pairs showed reduced lineage diversity following culture. Permutation analysis indicated preferential retention of Lineage 2 and depletion of Lineage 3 after culture. Technical replicates preserved dominant phylotype assignments (median SNP Jaccard similarity 0.863), while independently collected sputum specimens showed greater variability. Among 38 concordant single-lineage pairs, 35,540/38,311 (92.8%) pair-specific variant observations were shared after filtering and raw-read recovery, while 2,497 (6.5%) were sputum-unique and 274 (0.7%) culture-unique. Discordance was concentrated among variable variants; 88.0% of shared variants variable in at least one specimen had higher allele frequencies in culture. No sputum-unique WHO Grade 1 or 2 resistance-associated mutations were identified in the strain-controlled subset, whereas eight mixed-lineage sputum samples versus three matched cultures harboured such mutations. Higher baseline low-frequency variant burden showed non-significant trends towards delayed culture conversion (log-rank p=0.144) and unfavourable treatment outcomes (log-rank p=0.400). Conclusions: Direct-sputum WGS revealed M. tuberculosis lineage and low-frequency variant diversity that was not fully represented by matched culture-derived genomes, despite high overall genomic concordance. These findings highlight the complementary value of direct-sputum sequencing for characterising within-host diversity, while suggesting that the representation of bacterial populations following culture may vary across epidemiological settings. Further research is needed to improve the accuracy of minority-variant detection and establish the clinical relevance of diversity measured directly from sputum.

molecular biology↗

B-RANKO: An ncRNA Foundation Model with Bidirectional Decoder-Only Architecture

Ribonucleic acid (RNA) plays central roles in gene expression, regulation and catalysis, and has emerged as an important target for therapeutic design. While recent RNA foundation models have achieved strong performance on representation learning tasks, relatively few approaches support both native sequence generation and transferable representation learning within a single framework. We present B-RANKO, a 150M-parameter bidirectional decoder-only ncRNA foundation model that introduces a novel bidirectional autoregressive attention mechanism, enabling a single architecture to support both de novo sequence generation and representation learning. Pretrained on a large corpus derived from RNAcentral, Rfam and GARNET, B-RANKO generates biologically plausible and thermodynamically realistic RNA sequences that exhibit strong novelty relative to their closest matches in the pretraining corpus. We further show that B-RANKO can be efficiently fine-tuned for aptamer generation and achieves competitive performance on BEACON, with particularly strong results on RNA engineering tasks. B-RANKO is publicly available on GitHub at filipvucenik/B-RANKO, together with usage examples and instructions for downloading model weights and datasets.

molecular biology↗